• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyridines Imidazopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyridines

Introduction to 6-Bromo-2-Chloro-7-Methyl-3H-Imidazo[4,5-b]Pyridine (CAS No. 1388071-17-7)

6-Bromo-2-Chloro-7-Methyl-3H-Imidazo[4,5-b]Pyridine, identified by its CAS number 1388071-17-7, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the imidazopyridine class, a structural motif known for its broad spectrum of biological activities. The presence of bromo and chloro substituents, along with a methyl group, enhances its potential as a versatile intermediate in the synthesis of more complex molecules.

The imidazopyridine scaffold is particularly interesting due to its ability to interact with various biological targets, including enzymes and receptors. Recent studies have highlighted the importance of this scaffold in the development of drugs targeting neurological disorders, infectious diseases, and cancer. The specific arrangement of substituents in 6-Bromo-2-Chloro-7-Methyl-3H-Imidazo[4,5-b]Pyridine makes it a valuable building block for medicinal chemists seeking to design novel therapeutic agents.

In the context of drug discovery, the bromo and chloro atoms serve as key functional groups that can be further modified through various chemical reactions. These modifications allow for the exploration of diverse chemical space, enabling the optimization of pharmacokinetic properties and target binding affinity. The methyl group at the 7-position contributes to the steric environment of the molecule, influencing its overall biological activity.

Recent advancements in computational chemistry have facilitated the rapid screening of imidazopyridine derivatives for their potential biological effects. Virtual screening techniques have been employed to identify compounds that exhibit promising interactions with disease-related proteins. 6-Bromo-2-Chloro-7-Methyl-3H-Imidazo[4,5-b]Pyridine has been shown to exhibit inhibitory activity against certain kinases and other enzymes implicated in cancer progression. These findings underscore its potential as a lead compound in the development of targeted therapies.

The synthesis of 6-Bromo-2-Chloro-7-Methyl-3H-Imidazo[4,5-b]Pyridine involves multi-step organic transformations, typically starting from commercially available precursors. The introduction of bromo and chloro substituents is often achieved through halogenation reactions, which can be tailored to yield high regioselectivity. The presence of these halogen atoms also makes the compound suitable for cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings, which are widely used in medicinal chemistry for constructing complex molecular architectures.

One notable application of 6-Bromo-2-Chloro-7-Methyl-3H-Imidazo[4,5-b]Pyridine is in the development of small-molecule inhibitors for protein-protein interactions (PPIs). PPIs play a crucial role in many biological processes, and inhibiting these interactions has emerged as a promising strategy for treating various diseases. The imidazopyridine core provides a rigid framework that can mimic natural ligands and disrupt aberrant protein interactions. Preclinical studies have demonstrated that derivatives of this compound exhibit potent activity against specific PPIs, suggesting their therapeutic potential.

The impact of 6-Bromo-2-Chloro-7-Methyl-3H-Imidazo[4,5-b]Pyridine extends beyond oncology; it has also been explored in the treatment of infectious diseases. Emerging evidence suggests that imidazopyridines can interfere with bacterial virulence factors and metabolic pathways. The bromo and chloro substituents enhance binding affinity to bacterial targets, making this class of compounds attractive for developing novel antibiotics. Additionally, their ability to cross cell membranes ensures effective delivery to sites of infection.

In conclusion,6-Bromo-2-Chloro-7-Methyl-3H-Imidazo[4,5-b]Pyridine (CAS No. 1388071-17-7) represents a significant advancement in pharmaceutical chemistry. Its unique structural features and versatile reactivity make it a valuable tool for drug discovery efforts targeting a wide range of diseases. As research continues to uncover new applications for this compound, it is likely to remain at the forefront of medicinal chemistry innovation.

• 1824113-80-5(7-bromo-3-chloro-8-methylpyrido[2,3-b]pyrazine)
• 2172494-14-1(6-bromo-2-chloro-3H-imidazo4,5-bpyridine hydrochloride)
• 116605-69-7(7-Bromo-8-methylpyrido2,3-bpyrazine)
• 91996-63-3(6-Bromo-7-methyl-4-azabenzimidazole)
• 438190-89-7(6-bromo-2-chloro-3H-imidazo4,5-bpyridine)
• 1429376-88-4(7-Bromo-2,3-dichloro-8-methylpyrido2,3-bpyrazine)
• 954238-09-6(6-Bromo-2,7-dimethyl-3H-imidazo4,5-bpyridine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)